0 Comentários
0 Compartilhamentos
2KB Visualizações
Pesquisar
Conheça novas pessoas, crie conexões e faça novos amigos
-
Faça o login para curtir, compartilhar e comentar!
-
Cell & Gene Therapy Contract Research Organizations Market: Size, Trends, and Outlook to 2034The global Cell & Gene Therapy Contract Research Organizations Market was valued at USD 4.82 billion in 2024 and is projected to grow at a CAGR of 9.84% from 2025 to 2034, reaching USD 12.29 billion by 2034. Demand is being propelled by a rapidly expanding pipeline of advanced therapies, tightening regulatory expectations for CMC and clinical evidence, and...0 Comentários 0 Compartilhamentos 874 Visualizações
-
Cell and Gene Therapy (CGT) Logistic Market Business Opportunity, Development Factors and Future Prospects 2031 | Cencora, Inc（World Courier）, QuickStat, Associated CouriersCell and Gene Therapy (CGT) Logistic Market report has recently added by Analytic Insights Hub which helps to make informed business decisions. This research report further identifies the market segmentation along with their sub-types. Various factors are responsible for the market's growth, which are studied in detail in this research report. Cell and Gene Therapy (CGT) Logistic Market study...0 Comentários 0 Compartilhamentos 3KB Visualizações
-
Cell And Gene Therapy Clinical Trials Market 2033: Cardiovascular Therapies on the MapGlobal Cell and Gene Therapy Clinical Trials Market Overview The global cell and gene therapy (CGT) clinical trials market was valued at USD 10.75 billion in 2024 and is projected to reach USD 39.41 billion by 2033, growing at a CAGR of 15.58% from 2025 to 2033. The market growth is primarily driven by increasing R&D investments, rising patient demand for innovative therapies,...0 Comentários 0 Compartilhamentos 459 Visualizações
-
Gene Therapy Breakthroughs Reshaping Usher Syndrome MarketA new growth forecast report titled Usher Syndrome Market Share, Size, Trends, Industry Analysis Report, By Disease Type (Type1, Type2, Type3); By Treatment; By End-Use; By Region; Segment Forecast, 2024 – 2032 introduced by Polaris Market Research represents conclusive data on the overall market. It majorly targets to provide a detailed analysis of growth factors, challenges,...0 Comentários 0 Compartilhamentos 422 Visualizações
-
Gene Therapy for SCID Market Insights: Key Players, Vector Technologies, and Commercial StrategiesThe global gene therapy for SCID market is witnessing strong momentum as advancements in genetic engineering and cellular therapies reshape treatment pathways for rare immunodeficiency disorders. According to projections, the market is expected to expand at a robust compound annual growth rate (CAGR) and could reach a valuation of US$ 2.0 billion by 2034, reflecting the growing adoption of...0 Comentários 0 Compartilhamentos 675 Visualizações
-
Gene Therapy Impact On Ophthalmoplegia MarketThe healthcare landscape in the US is continually evolving, driven by advancements in diagnostics and treatment for complex neurological and ophthalmic conditions. Among these, the market addressing Ophthalmoplegia—a condition characterized by paralysis or weakness of the eye muscles—is showing stable, promising growth. New market data indicates that innovations in management and...0 Comentários 0 Compartilhamentos 446 Visualizações
-
Gene Therapy Market Forecast, Emerging Applications and Industry Landscape (2025-2033) |UnivDatosAccording to the UnivDatos, the gene therapy market was valued at approximately USD 9.2 billion in 2024 and is expected to grow at a substantial CAGR of around 30.1% during the forecast period (2025-2033), owing to the growing gene therapy pipeline. In the ever-evolving landscape of medical science, gene therapy stands as a beacon of hope. This groundbreaking field has witnessed remarkable...0 Comentários 0 Compartilhamentos 1KB Visualizações
-
Gene Therapy Market Growth, Drivers & Opportunities (2025-2033) | UnivDatosAccording to UnivDatos - The Gene Therapy Market was valued at USD 9.2 Billion in the year 2024 and is expected to grow at a strong CAGR of around 30.1% during the forecast period (2025-2033) owing to the growing gene therapy pipeline. North America, with its cutting-edge research institutions, innovative biotech companies, and robust healthcare infrastructure, stands at the forefront of...0 Comentários 0 Compartilhamentos 866 Visualizações
-
Gene Therapy Market Segments, Emerging Technologies and Growth by Forecast to 2031United States of America– 29 Oct 2025- The Insight Partners is proud to announce its newest market report, "An In-depth Analysis of the Gene Therapy Market". The report provides a holistic view of the markets and describes the current scenario as well as growth estimates of the market during the forecast period. Overview of Gene Therapy Market There has...0 Comentários 0 Compartilhamentos 489 Visualizações
-
Gene Therapy Market Size, Growth, Trends, Forecast (2023-2030)According to the Universal Data Solutions analysis, the surge in the incidences of rare genetic disorders and associated surge in the demand for targeted therapies will drive the global scenario of the rare genetic disorders treatment and as per their “Gene Therapy Market” report, the global market was valued at USD 5663.1 million in 2022, growing at a CAGR of 30.1% during the...0 Comentários 0 Compartilhamentos 522 Visualizações
-
Global CRISPR Gene-Editing Market Overview, Growth Analysis, Trends and Forecast By 2032"Regional Overview of Executive Summary CRISPR Gene-Editing Market by Size and Share The global CRISPR gene-editing market size was valued at USD 1.83 billion in 2024 and is expected to reach USD 14.74 billion by 2032, at a CAGR of 29.8% during the forecast period A consistent market research report like CRISPR Gene-Editing Market report extends reach to the...0 Comentários 0 Compartilhamentos 1KB Visualizações
-
Osteogenesis Imperfecta Treatment Market - Trend, Growth, Forecast 2024–2032Introspective Market Research (IMR) has unveiled its latest strategic analysis on the Global Osteogenesis Imperfecta (OI) Treatment Market. The report highlights the critical role of specialized pharmaceuticals and emerging gene therapies in managing this rare, inherited connective tissue disorder, often referred to as "brittle bone disease." The market, which was valued at USD 722.9 Million in...0 Comentários 0 Compartilhamentos 71 Visualizações
Páginas impulsionada
© 2025 Scenario.press - libera espressione
Portuguese (Brazil)
Portuguese (Brazil)
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Greek